Vuzix Corporation designs, manufactures, and markets artificial intelligence (AI)-powered smart glasses, waveguides, and augmented reality (AR) technologies in North America, Europe, the Asia Pacific, and internationally.
FAIL · Does not pass the screen
2.06 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago
Screened 2026-10-23 · the tape above runs as of 18:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price2.06 USD at the 23 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.35)
Last reviewed23 Oct 2026 (5 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 2.06 against the desk's fair-value range, base estimate 4.39, over the last year.
Positioning political selling, disclosed 2026-09-03
Options put/call open interest 0.35, read 2026-10-27
Ethical does not pass the values gate
Price2.06 USD
Fair value4.39
Ethical score70.0/100
Our investment reviews on this name
2026-10-15Read Markdown2.56-19.5% to today ✓Accumulation gives way to Markdown after a 7% slide in 13 days
2026-10-02Read Accumulation2.75-25.1% to today Markdown gives way to Accumulation after a 22% rise in 2 weeks
2026-09-16Read Markdown2.26-8.8% to today ✓Accumulation gives way to Markdown
2026-08-16Read Accumulation2.26-8.8% to today Markup gives way to Accumulation after a 28% slide in 6 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Vuzix Corp holds its Markdown at $2.06. The statistical read favours the sellers, held for 20 days.
As held on the ledger · 2026-10-23
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 20 days
Price at the screen
$2.06
Valuation
N/A trailing · -5.38 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.75
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
2.50%
Below 33%
Interest-bearing debt is just 2.5% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
56.84%
Below 49%
Money owed to the company is 56.8% of assets, above the 49% limit.
Fail
Revenue purity
10.70%
Below 5%
10.7% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Vuzix's business is fine, but its receivables are about 57% of its assets, just over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VUZI's ethical verdict changes
Today VUZI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VUZI trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-22Markdown$2.19-14.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 14.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading bearish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-10-15Markdown · changed$2.56-6.9%Entry 7
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 21.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-09-16Markdown · changed$2.26+0.0%Entry 5
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 27.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-07-18Markup$3.12+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 45% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 8%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (1 analysts) rates it none, with a mean price target of $6.
2026-07-03Markup$3.12+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$3.12Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.